Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

DeltaHealth, Backed by Fidelity, Opens Shanghai Cardiovascular Hospital

publication date: Sep 8, 2016
DeltaHealth has opened its first cardiovascular hospital in Shanghai, the first of a chain it plans to build in China. The hospital, which worked with Columbia HeartSource to develop procedures, is backed by Eight Roads Ventures China, the investment arm of Fidelity International. DeltaHealth first opened an outpatient clinic in Hongqiao, Shanghai in 2013. In its first phase, the new hospital has 202 beds; it plans to raise that number to 350 when the hospital is completely built out. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital